Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
AUTOR(ES)
Ucciferri, Claudio, Falasca, Katia, Vignale, Francesca, Di Nicola, Marta, Vecchiet, Jacopo
FONTE
Braz J Infect Dis
DATA DE PUBLICAÇÃO
2016-08
RESUMO
Documentos Relacionados
- A reduced dose of darunavir/ritonavir is effective in PI-experienced HIV-infected patients
- Long-term virologic and immunologic responses on darunavir/ritonavir - containing regimens among highly antiretroviral therapy-experienced patients: 7-year follow-up of a prospective cohort study in São Paulo, Brazil
- High rate of virologic suppression with darunavir/ritonavir plus optimized background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil
- Erratum in «High rate of virologic supression with darunavir/ritonavir plus optimazed background therapy among highly antiretroviral-experienced HIV-infected patients: results of a prospective cohort study in São Paulo, Brazil»
- Ritonavir-Saquinavir Dual Protease Inhibitor Compared to Ritonavir Alone in Human Immunodeficiency Virus-Infected Patients